Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

ALT

Altimmune (ALT)

Altimmune Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALT

<< Previous 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>

Date	Time	Source	Headline	Symbol	Company
11/30/2018	4:21PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
11/27/2018	4:37PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
11/13/2018	5:04PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ALT	Altimmune Inc
11/13/2018	4:59PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
11/13/2018	4:50PM	GlobeNewswire Inc.	Altimmune Announces Third Quarter 2018 Financial Results and Provides Corporate Update	NASDAQ:ALT	Altimmune Inc
10/22/2018	4:34PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
10/17/2018	6:06AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ALT	Altimmune Inc
10/11/2018	4:20PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALT	Altimmune Inc
10/09/2018	5:22PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ALT	Altimmune Inc
10/09/2018	9:29AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ALT	Altimmune Inc
10/09/2018	9:15AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
10/05/2018	11:01AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ALT	Altimmune Inc
10/04/2018	4:08PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALT	Altimmune Inc
10/04/2018	4:03PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ALT	Altimmune Inc
10/04/2018	10:58AM	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:ALT	Altimmune Inc
10/01/2018	5:26PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
10/01/2018	5:18PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:ALT	Altimmune Inc
09/28/2018	7:52AM	Edgar (US Regulatory)	Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)	NASDAQ:ALT	Altimmune Inc
09/28/2018	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ALT	Altimmune Inc
09/26/2018	5:24PM	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:ALT	Altimmune Inc
09/25/2018	6:08AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
09/24/2018	1:50PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ALT	Altimmune Inc
09/24/2018	8:12AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
09/14/2018	9:15AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALT	Altimmune Inc
09/13/2018	5:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
09/12/2018	5:06PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
09/10/2018	7:25PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ALT	Altimmune Inc
09/04/2018	4:02PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
08/31/2018	4:09PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
08/17/2018	4:40PM	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:ALT	Altimmune Inc